Evidence map›Paper›PMID 31817190›Full record

ReviewInternational journal of environmental research and public health2019

Atrial Fibrillation in Athletes-Features of Development, Current Approaches to the Treatment, and Prevention of Complications.

Evgeny Achkasov, Sergey Bondarev, Victor Smirnov, Zbigniew Waśkiewicz, Thomas Rosemann, Pantelis Theodoros Nikolaidis, Beat Knechtle

Abstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Effect of SGLT2 inhibitors on atrial fibrillation recurrence after catheter ablation in patients with type 2 diabetes in the United States: a TriNetX database study.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Evgeny AchkasovDepartment of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.
Sergey BondarevDepartment of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.
Victor SmirnovDepartment of Hospital Therapy, Saint-Petersburg State Pediatric Medical University Ministry of Health of Russia, Saint Petersburg 194100, Russia.
Zbigniew WaśkiewiczDepartment of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.ORCID 0000-0003-4885-6417
Thomas RosemannInstitute of Primary Care, University of Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-6436-6306
Pantelis Theodoros NikolaidisExercise Physiology Laboratory, 18450 Nikaia, Greece.ORCID 0000-0001-8030-7122
Beat KnechtleExercise Physiology Laboratory, 18450 Nikaia, Greece.ORCID 0000-0002-2412-9103

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) is one of the most common types of cardiac arrhythmias. This review article highlights the problem of the development of atrial fibrillation in individuals engaged in physical activity and sports. Predisposing factors, causes, and development mechanisms of atrial fibrillation in athletes from the perspective of the authors are described. Methods of treatment, as well as prevention of thromboembolic complications, are discussed. Directions for further studies of this problem and prevention of complications are proposed.

Indexed as

AthletesAtrial FibrillationHumansRisk FactorsSportsThromboembolismathletesatrial fibrillationCardiomyopathyechocardiographymyocardial stiffnessoral anticoagulantsover-training syndromepathological athlete heartPETSPECT

Identifiers

PMID31817190
PMCPMC6950061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.